Pursuing the Footsteps of the Fathers and Inheriting the Revolutionary Spirit Peak Party Members Visit the Site of the Gutian Conference
Release time:
2021-06-11
News from our newspaper "I volunteer to join the Communist Party of China, support the party's program, abide by the party's constitution, and fulfill the obligations of a party member..." 6# April 6# On the morning of , at the site of the Gutian Conference in Shanghang County, Fujian Province, 30 More than a peak party member solemnly raised his right fist facing the party flag to review the oath of joining the party.
Visit and study at the Red Education Base and review the oath of joining the Party are important contents of the study and education of Party history. Yu Jianhong, Qin Xuping and Chen Tianci, members of the group's party Committee, party members of various branches of the group's headquarters, and secretaries of grass-roots party organizations under the group's party Committee, totaling more than 30 , visited and studied at the Gutian conference site. Party members visited the Gutian Conference site, the Chairman's Memorial Garden, the Gutian Conference Memorial Hall and other red attractions, and presented flower baskets to the statue of Comrade Mao Zedong.
Gutian Conference was the 9th Party Congress held by the Fourth Army of the Chinese Workers' and Peasants' Red Army in Gutian Village, Shanghang County, Fujian Province from 1929 to 28 to 29 . This meeting summed up the experiences and lessons of army building since the founding of the fourth Red Army, established the principle of the party's absolute leadership over the Red Army, combined Marxism-Leninism with the concrete practice of China's revolutionary struggle, and solved the fundamental problem of how to maintain the party's proletarian vanguard nature and build a new type of people's army by strengthening the party's ideological work. It is of great significance in the history of the development of the Communist Party of China and the Workers' and the Red Army. During the visit and study period, party members visited the display of revolutionary cultural relics, listened to the explanation, got a close understanding of the revolutionary process of the ancestors in building the party and army under difficult conditions, and accepted the spiritual baptism of ideals and beliefs. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31